EC Number |
Inhibitors |
Structure |
---|
3.4.22.B62 | (2E)-2-[(2,3-dimethyl-1,4-dioxidoquinoxalin-6-yl)methylidene]-N-(2-phenylethyl)hydrazinecarboxamide |
32% inhibiton at 0.01 mM |
|
3.4.22.B62 | (2E)-2-[(2-amino-3-cyano-1,4-dioxidoquinoxalin-6-yl)methylidene]-N-(2-phenylethyl)hydrazinecarboxamide |
61% inhibiton at 0.01 mM |
|
3.4.22.B62 | (2E)-2-[(2-amino-3-cyano-1,4-dioxidoquinoxalin-6-yl)methylidene]-N-(prop-2-en-1-yl)hydrazinecarbothioamide |
39% inhibiton at 0.01 mM |
|
3.4.22.B62 | (2E)-2-[(2-amino-3-cyano-1,4-dioxidoquinoxalin-6-yl)methylidene]-N-butylhydrazinecarboxamide |
27% inhibiton at 0.01 mM |
|
3.4.22.B62 | (2E)-N'-(2-[(naphthalen-1-ylmethyl)sulfanyl]acetyl)-3-phenylprop-2-enehydrazide |
- |
|
3.4.22.B62 | (2Z)-2-[(2E)-[(2,3-dimethyl-1,4-dioxidoquinoxalin-6-yl)methylidene]hydrazinylidene]-3-(prop-2-en-1-yl)-1,3-thiazolidin-4-one |
22% inhibiton at 0.01 mM |
|
3.4.22.B62 | (6,7-difluoro-3-methyl-1,4-dioxidoquinoxalin-2-yl)(phenyl)methanone |
17% inhibiton at 0.01 mM |
|
3.4.22.B62 | 2-([4-benzyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]sulfanyl)-1-(1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-one |
- |
|
3.4.22.B62 | 2-methylquinoxaline 1,4-dioxide |
8% inhibiton at 0.01 mM |
|
3.4.22.B62 | 3-amino-7-([ethyl[(2Z)-3-phenylprop-2-en-1-yl]amino]methyl)quinoxaline-2-carbonitrile 1,4-dioxide |
45% inhibiton at 0.01 mM |
|